-
New MS Drug Ocrevus Gets Possible Bad News About Side Effects Soon After Good News About Sales Projections
Ocrevus – Progressive Multifocal Leukoencephalopathy (PML) Reported As Possible Side Effect In Germany, Says Drug Maker Roche (Posted by Tom Lamb at DrugInjuryWatch.com) In March 2017 the FDA approved Ocrevus (ocrelizumab injection)…
-
May 2017 “Dear Doctor” Letter About Aranesp Cases Of Stevens-Johnson Syndrome (SJS) And Toxic Epidermal Necrolysis (TEN)
Current U.S. Version Of Full Prescribing Information Document For Aranesp Mentions Skin Rash Among Other Serious Allergic Reactions (Posted by Tom Lamb at DrugInjuryWatch.com) Aranesp (darbepoetin alfa) products for subcutaneous and intravenous…
-
Farxiga MDL Created In April 2017; Assigned to Federal Court Judge Lorna Schofield In New York
This Consolidated Litigation Involves Farxiga And Xigduo XR; Side Effects Include Diabetic Ketoacidosis And Kidney Damage (Posted by Tom Lamb at DrugInjuryWatch.com) By means of this post, we are updating our March…
-
Growing Concern About Reports Of Children Who Developed Neuro-Psychiatric Problems After Taking MiraLAX
FDA-Funded Study About The Use Of Polyethylene Glycol In The Pediatric Population Currently Underway At Children's Hospital Of Philadelphia (Posted by Tom Lamb at DrugInjuryWatch.com) MiraLAX is a popular over-the-counter laxative medicine…
